國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Exploring pancreatic metabolism and ...

BM Reddy, Aramati.

Exploring pancreatic metabolism and malignancy

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Exploring pancreatic metabolism and malignancyedited by Ganji Purnachandra Nagaraju, Aramati BM Reddy.
其他作者:	Nagaraju, Ganji Purnachandra.
出版者:	Singapore :Springer Singapore :2019.
面頁冊數:	xii, 268 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	PancreasCancer
電子資源:	https://doi.org/10.1007/978-981-32-9393-9
ISBN:	9789813293939$q(electronic bk.)

Exploring pancreatic metabolism and malignancy
Exploring pancreatic metabolism and malignancy[electronic resource] /edited by Ganji Purnachandra Nagaraju, Aramati BM Reddy. - Singapore :Springer Singapore :2019. - xii, 268 p. :ill., digital ;24 cm.

Chapter 1. Biology of pancreas and possible diseases -- Chapter 2. Pancreatitis: Clinical aspects of inflammatory phenotypes -- Chapter 3. Diabetes and Pancreatic Cancer - A Bidirectional Relationship Perspective -- Chapter 4. Metabolic Adaptations in Diabetes Mellitus and Cancer -- Chapter 5. Role of Mitochondria in pancreatic metabolism, diabetes and cancer -- Chapter 6. Targeting Mitochondrial Enzymes in Pancreatic Cancer -- Chapter 7. Diabetes with Pancreatic ductal adenocarcinoma -- Chapter 8. Role of Inflammatory Cytokines in the initiation and progression of Pancreatic Cancer -- Chapter 9. Perspectives and molecular understanding of pancreatic cancer stem cells -- Chapter 10. The Role of Hypoxia Inducible Factor-1a in Pancreatic Cancer and Diabetes Mellitus -- Chapter 11. Role of Heat shock protein 90 in Diabetes and Pancreatic Cancer Management -- Chapter 12. Insulin resistance is a common core tethered to diabetes and pancreatic cancer risk -- Chapter 13. Immunotherapy for Diabetogenic Pancreatitis and Pancreatic Cancer: An Update -- Chapter 14. Exosomes: Mediators and Therapeutic Targets of Diabetes and Pancreatic Cancer -- Chapter 15. Methods and models in exploring pancreatic functions.

This book comprehensively describes the association between metabolic syndrome and pancreatic cancer progression, and the mechanism of action and target definition with a view to drug discovery. Metabolic syndrome, which includes adnominal obesity, hypertension, dyslipidemia, and hyperglycemia, has recently been shown to play an important role in the etiology and progression of various cancers. Further, obesity and diabetes have been associated with an increased incidence of gastric cancers. The book reviews the key biological mechanisms underlying the association between metabolic dysregulation, including obesity-associated enhancement of growth factor signaling, inflammation, and perturbation in pancreatic cancer cell growth and metastasis. It also illustrates the role of the inflammatory signaling pathway in metabolic diseases as well as tumor growth and explores the potential of these pathways as the rational targets for pancreatic cancer therapy. Lastly, the book offers a comprehensive description of the challenges associated with diabetes and pancreatic cancer therapy.

ISBN: 9789813293939$q(electronic bk.)

Standard No.: 10.1007/978-981-32-9393-9doiSubjects--Topical Terms:

855085
Pancreas
--Cancer

LC Class. No.: RC280.P25 / E975 2019

Dewey Class. No.: 616.99437

Exploring pancreatic metabolism and malignancy
LDR:03323nmm a2200325 a 4500 001 569190
003 DE-He213
005 20200205142047.0
006 m d
007 cr nn 008maaau
008 200723s2019 si s 0 eng d
020 $a 9789813293939$q(electronic bk.)
020 $a 9789813293922$q(paper)
024 7 $a 10.1007/978-981-32-9393-9 $2 doi
035 $a 978-981-32-9393-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.P25 $b E975 2019
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99437 $2 23
090 $a RC280.P25 $b E96 2019
245 0 0 $a Exploring pancreatic metabolism and malignancy $h [electronic resource] / $c edited by Ganji Purnachandra Nagaraju, Aramati BM Reddy.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2019.
300 $a xii, 268 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1. Biology of pancreas and possible diseases -- Chapter 2. Pancreatitis: Clinical aspects of inflammatory phenotypes -- Chapter 3. Diabetes and Pancreatic Cancer - A Bidirectional Relationship Perspective -- Chapter 4. Metabolic Adaptations in Diabetes Mellitus and Cancer -- Chapter 5. Role of Mitochondria in pancreatic metabolism, diabetes and cancer -- Chapter 6. Targeting Mitochondrial Enzymes in Pancreatic Cancer -- Chapter 7. Diabetes with Pancreatic ductal adenocarcinoma -- Chapter 8. Role of Inflammatory Cytokines in the initiation and progression of Pancreatic Cancer -- Chapter 9. Perspectives and molecular understanding of pancreatic cancer stem cells -- Chapter 10. The Role of Hypoxia Inducible Factor-1a in Pancreatic Cancer and Diabetes Mellitus -- Chapter 11. Role of Heat shock protein 90 in Diabetes and Pancreatic Cancer Management -- Chapter 12. Insulin resistance is a common core tethered to diabetes and pancreatic cancer risk -- Chapter 13. Immunotherapy for Diabetogenic Pancreatitis and Pancreatic Cancer: An Update -- Chapter 14. Exosomes: Mediators and Therapeutic Targets of Diabetes and Pancreatic Cancer -- Chapter 15. Methods and models in exploring pancreatic functions.
520 $a This book comprehensively describes the association between metabolic syndrome and pancreatic cancer progression, and the mechanism of action and target definition with a view to drug discovery. Metabolic syndrome, which includes adnominal obesity, hypertension, dyslipidemia, and hyperglycemia, has recently been shown to play an important role in the etiology and progression of various cancers. Further, obesity and diabetes have been associated with an increased incidence of gastric cancers. The book reviews the key biological mechanisms underlying the association between metabolic dysregulation, including obesity-associated enhancement of growth factor signaling, inflammation, and perturbation in pancreatic cancer cell growth and metastasis. It also illustrates the role of the inflammatory signaling pathway in metabolic diseases as well as tumor growth and explores the potential of these pathways as the rational targets for pancreatic cancer therapy. Lastly, the book offers a comprehensive description of the challenges associated with diabetes and pancreatic cancer therapy.
650 0 $a Pancreas $x Cancer $x Molecular aspects. $3 855085
650 1 4 $a Cancer Research. $3 273660
650 2 4 $a Metabolic Diseases. $3 274217
650 2 4 $a Human Physiology. $3 274509
650 2 4 $a Diabetes. $3 274215
650 2 4 $a Immunology. $3 189152
700 1 $a Nagaraju, Ganji Purnachandra. $3 798639
700 1 $a BM Reddy, Aramati. $3 855084
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-981-32-9393-9
950 $a Biomedical and Life Sciences (Springer-11642)